Our Website Uses Cookies 


We and the third parties that provide content, functionality, or business services on our website may use cookies to collect information about your browsing activities in order to provide you with more relevant content and promotional materials, on and off the website, and help us understand your interests and improve the website.


For more information, please contact us or consult our Privacy Notice.

Your binder contains too many pages, the maximum is 40.

We are unable to add this page to your binder, please try again later.

This page has been added to your binder.

Covington Advises Merck on €2.1 Billion Acquisition of Animal Health Company

December 14, 2018

WASHINGTONCovington advised Merck & Co., Inc. on its acquisition of Antelliq Group for approximately €2.1 billion ($2.4 billion) plus the assumption of €1.15 billion of debt. Antelliq will be wholly owned and separately operated subsidiary within the Merck Animal Health Division.

Antelliq is an animal intelligence group focused on animal identification, traceability and monitoring solutions, the fastest growing part of the animal health industry. These solutions help veterinarians, farmers and pet owners gather critical data to improve the management, health, and well-being of livestock and pets.

The increasing use of digital technology in animal agriculture is driven by the growing demand for protein, food traceability and food safety. Identification and monitoring technologies will help optimize disease prediction and treatment, and this acquisition will provide Merck Animal Health with a large, established customer base in both areas.

The Covington team was led by Catherine Dargan, Michael Riella, and Louise Nash.

Share this article: